脑萎缩与血栓切除术后功能结局及恢复轨迹的关联:ESCAPE-NA1试验的事后分析
该研究为ESCAPE-NA1试验的回顾性事后分析,纳入1102例接受血管内血栓切除术的患者,采用GCA量表评估皮质萎缩、用CC/IT比值评估皮质下萎缩。结果显示,脑萎缩与90天mRS更差、mRS0-2比例更低及死亡率更高相关,且随访中mRS随时间持续更差。
要点
- 皮质萎缩(GCA≥1 vs GCA 0)与90天mRS更差相关(acOR=1.62,95%CI 1.22-2.16)。
- 皮质下萎缩(CC/IT比值每增加0.01)与90天mRS更差相关(acOR=1.07,95%CI 1.04-1.11)。
- GCA=1者30天mRS较GCA=0者高0.41(95%CI 0.18-0.65),90天仍差0.72(95%CI 0.49-0.95)。
核心结论
- 在急性非增强CT上目测评估的脑萎缩患者,血管内血栓切除术后恢复较差,90天功能结局较无脑萎缩者更差。
- 该结果可能有助于医生在与患者及家属规划血栓切除术后照护时提供恢复预期。
研究设计与样本
- ESCAPE-NA1试验的回顾性事后分析,纳入1102例参与者(平均年龄69.5±13.7岁;554例男性)。
- 采用GCA量表(含区域特异性量表)评估皮质萎缩,采用CC/IT比值评估皮质下萎缩。
- 主要结局为90天mRS(序贯移位分析),次要结局为随时间变化的mRS评分。
- 校正年龄、性别、基线NIHSS、最终梗死体积、卒中侧别、总Fazekas评分及nerinetide-阿替普酶交互作用。
- 对具有MRI数据的患者额外进行敏感性分析。
主要发现
- 818例(74%)GCA=0,220例(20%)GCA=1,64例(6%)GCA=2/3;CC/IT比值中位数0.12(IQR 0.10-0.15)。
- 皮质萎缩(GCA≥1 vs GCA 0)与90天mRS更差相关(acOR=1.62,95%CI 1.22-2.16;p=0.001),90天mRS0-2比例更低(aOR=0.65,95%CI 0.45-0.94;p=0.022),死亡率更高(aOR=2.12,95%CI 1.28-3.5;p=0.003),无论评估区域如何。
- 皮质下萎缩(CC/IT比值每增加0.01)与90天mRS更差相关(acOR=1.07,95%CI 1.04-1.11;p<0.001),90天mRS0-2比例更低(aOR=0.92,95%CI 0.88-0.97;p=0.001)。
- 随访中mRS测量存在异质性:萎缩分级越高,mRS评分越差(p<0.001);与GCA=0相比,GCA=1者30天mRS调整后差值0.41(95%CI 0.18-0.65),90天仍更差,调整后差值0.72(95%CI 0.49-0.95)。
- 严重皮质萎缩(GCA 2/3)者26/63(41%)达到良好功能结局(mRS0-2),严重皮质下萎缩(CC/IT比值最高四分位)者124/274(45%)达到,而无皮质萎缩者539/812(66.4%)、CC/IT比值最低四分位者209/274(76%)达到。
关键数值与推荐
- 皮质萎缩定义:GCA≥1 vs GCA 0。
- 皮质下萎缩定义:CC/IT比值每增加0.01。
- 主要结局:90天mRS序贯移位分析。
- 次要结局:随时间变化的mRS评分。
临床怎么用
- 原文未据此给出推荐。
- 作者认为该结果可能有助于医生在与患者及家属规划血栓切除术后照护时提供恢复预期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Brain frailty may impair the ability of acute stroke patients to cope with the injury, irrespective of their chronologic age, resulting in impaired recovery. We aim to investigate the impact of brain atrophy on functional outcome assessed at different time points after endovascular thrombectomy (EVT). METHODS: In this retrospective post hoc analysis of the ESCAPE-NA1 trial, we analyzed CT imaging data for cortical atrophy by using the GCA scale, including region-specific scales, and subcortical atrophy by using the intercaudate distance to inner table width (CC/IT) ratio. The primary outcome was 90-day mRS (ordinal shift analysis), and the secondary outcome was the mRS score over time. Adjustments were made for age, sex, baseline NIHSS, final infarct volume, stroke laterality, total Fazekas score, and nerinetide-alteplase interaction. Sensitivity analyses were additionally performed in only those patients for whom MRI data were available. RESULTS: Of 1,102 participants (mean age of 69.5 ± 13.7 years; 554 men), 818 (74%) had GCA = 0, 220 (20%) had GCA = 1, and 64 (6%) had GCA = 2/3. The median CC/IT ratio was 0.12 (IQR0.10-0.15). Cortical atrophy (GCA ≥ 1 vs GCA 0) was associated with worse 90-day mRS (acOR = 1.62 [95% CI 1.22-2.16]; p = 0.001), lower rates of 90-day mRS0-2 (aOR = 0.65 [95% CI 0.45-0.94]; p = 0.022), and higher mortality (aOR = 2.12 [95% CI 1.28-3.5]; p = 0.003), regardless of the region assessed. Subcortical atrophy was associated with worse 90-day mRS (acOR [per 0.01 increase in CC/IT ratio] = 1.07 [95% CI 1.04-1.11]; p < 0.001) and lower rates of 90-day mRS0-2 (aOR = 0.92 [95% CI 0.88-0.97]; p = 0.001). Furthermore, with various degrees of atrophy, we observed heterogeneity in mRS measurements during follow-up: worse mRS scores for higher atrophy grades (p < 0.001). Compared with participants with GCA = 0, the mRS for participants with GCA = 1 was higher at 30 days (adjusted difference = 0.41 [95% CI 0.18-0.65]) and remained worse at 90 days (adjusted difference = 0.72 [95% CI 0.49-0.95]). Similar effects were seen for participants with worse cortical atrophy, regardless of the region assessed, and worse subcortical atrophy. Furthermore, 26/63(41%) and 124/274(45%) patients with severe cortical/subcortical atrophy (GCA 2/3 and highest CC/IT ratio quartile, respectively) achieved good functional outcome (mRS0-2), compared with 539/812(66.4%) with no cortical atrophy and 209/274(76%) in the lowest CC/IT ratio quartile. DISCUSSION: In this large RCT-derived population, participants with brain atrophy, as visually assessed on acute noncontrast computed tomography imaging, showed less favorable stroke recovery after EVT and worse 90-day functional outcomes compared with participants without brain atrophy. This may support physicians with recovery expectations when planning post-EVT care with patients and their families.
引用
- Benali F, Fladt J, Jaroenngarmsamer T, et al. Association of Brain Atrophy With Functional Outcome and Recovery Trajectories After Thrombectomy: Post Hoc Analysis of the ESCAPE-NA1 Trial. Neurology. 2023. PMID: 37591777. doi:10.1212/WNL.0000000000207700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。